|
|
|
|
Capacity Development
- A Kernel for Open Source Drug Discovery in Tropical Diseases
Orti L, Carbajo RJ, Pieper U, Eswar N, Maurer SM, et al. (2009) A Kernel for Open Source Drug Discovery in Tropical Diseases. PLoS Negl Trop Dis 3(4).
- An Ex-Ante and Ex-Post Perspective: Mode of Entry for Emerging Markets (2009)
M. Allarakhia; Chapter Submission: Initiative for Policy Dialogue-Volume on Intellectual Property Rights.
- Can Open-Source Drug R&D Repower Pharmaceutical Innovation?
B Munos; Clinical Pharmacology & Therapeutics 87, 534-536 (May 2010).
- Data sharing and intellectual property in a genomic epidemiology network: policies for large-scale research collaboration
DA Chokshi, M Parker, DP Kwiatkowski; Bull World Health Organ. 2006 May;84(5):382-7.
- Developing a framework for understanding and enabling open source drug discovery
M. Allarakhia; Expert Opinion on Drug Discovery, 5(8), 2010.
- Ethical Data Release in Genome-Wide Association Studies in Developing Countries
M Parker, SJ Bull, J de Vries, T Agbenyega, OK Doumbo, et al.; PLoS Med 6(11), 2009.
- Facilitating creative partnerships in biopharmaceutical research
Lawrence, S; CQDM, Biotechnology Focus, 2009.
- How open innovation could reinvigorate the pharmaceutical industry with fresh R&D opportunities
T. Senderovitz; Expert Rev. Clin. Pharmacol. 2(6), 585-587 (2009).
- Is open innovation the way forward for big pharma?
J. Hunter and S. Stephens; Nature Reviews Drug Discovery 9, 87-88 (February 2010).
- Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery
M.R. Barnes, L. Harland, S.M. Foord, M.D. Hall1, I. Dix, S. Thomas, B.I. Williams-Jones, C.R. Brouwer; Nature Reviews Drug Discovery 8, 701-708 (September 2009).
- Managing Knowledge Assets under Conditions of Radical Change: The Case of the Pharmaceutical Industry (2010)
M. Allarakhia and S. Walsh; Technovation Special Issue Submission.
- Open Innovation in South Africa: case studies in nanotechnology, biotechnology, and open source software development
M. Gastrow; Education, Science and Skills Development Research Programme. Human Sciences Research Council, South Africa.
- Open innovation networks between academia and industry: an imperative for breakthrough therapies
T. Melese, S.M. Lin, J.L. Chang, N.H. Cohen; Nature Medicine 15, 502 - 507 (2009).
- Open source biopharmaceutical innovation - A mode of entry for firms in emerging markets (2009)
M. Allarakhia; Journal of Business Chemistry, January 2009.
- Open Source Biotechnology: A Drug for Developing Countries' Health Problems?
M.H.M. Schellekens; Tilburg University - Faculty of Law (TILT)
Working Paper Series, May 2007.
- Open-Minded to Open Innovation and Precompetitive Collaboration
J A Wagner; Clinical Pharmacology & Therapeutics 87, 511-515 (May 2010).
- Partnerships for Innovation and Global Health: NIH International Technology Transfer Activities
L.A.Salicrup, M.L.Rohrbaugh; IP Handbook of Best Practices- Putting Intellectual Property to Work: Experiences from Around the World.
- Research-Industry Collaborations Enabling Green Nanotechnology: An Indian Case Analysis
M. Allarakhia; IAMOT 2009 Presentation.
|
|
|
|
